For uninsured patients, typical out-of-pocket costs for spinal cord stimulation are 15,000 - 50,000 or more. The news follows after Boston Scientific was able to further extend its pain mitigation efforts, acquiring Intercept Intraosseous Nerve Ablation System developer, Relievant Medsystems for an upfront cash payment of $850m.Įlsewhere in the field of neurostimulation, Dutch competitor Onward Medical has started a Netherlands-based clinical feasibility study to assess its ARC-IM neurostimulator’s ability to improve haemodynamic instability in spinal cord injury patients. How much you can expect to pay out of pocket for spinal cord stimulation, including what people paid. The market is largely dominated by a back-and-forth between Boston Scientific and its US-based competitor, Medtronic. They’re used to treat many forms of chronic pain, including back pain after failed surgery. GlobalData’s Medical Device Centre details how there are as many as 79 spinal cord stimulator devices currently in the development pipeline, with 54 of those in clinical development. Sales of spinal cord stimulation devices are expected to rebound strongly this year as the easing of the COVID-19 crisis drives the return of elective procedures, according to a survey of doctors. Spinal cord stimulators are implanted devices that help block pain signals from your brain. ![]() At the same time the company’s FAST Therapy study, a multiple prospective and real-world study taking place across Europe and the United States similarly saw 88% of SCS patients reporting 50% or greater pain relief.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |